Esophagus Cancer Recruiting Phase 2 / 3 Trials for Tegafur (DB09256)

IndicationStatusPhase
DBCOND0032126 (Esophagus Cancer)Recruiting2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs